Trials / Completed
CompletedNCT00772512
A Study Of The Effect Of PF-04802540 On Sleep Measures
Subject- And Investigator-Blinded, Sponsor-Open, Randomized, Single-Dose, Placebo-Controlled, 3-Way Crossover Study To Study Effects Of PF-04802540 On Polysomnography Endpoints In Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Taisho Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine if PF-04802540 decreases REM sleep.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PF-04802540 | 5 mg capsule, single dose |
| DRUG | PF-04802540 | 15 mg capsule, single dose |
| DRUG | Placebo | Placebo capsule, single dose |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2008-10-15
- Last updated
- 2010-03-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00772512. Inclusion in this directory is not an endorsement.